BR9710377A - Gr-nulos de derivados de hexahidropirazina administr veis por via oral - Google Patents

Gr-nulos de derivados de hexahidropirazina administr veis por via oral

Info

Publication number
BR9710377A
BR9710377A BR9710377A BR9710377A BR9710377A BR 9710377 A BR9710377 A BR 9710377A BR 9710377 A BR9710377 A BR 9710377A BR 9710377 A BR9710377 A BR 9710377A BR 9710377 A BR9710377 A BR 9710377A
Authority
BR
Brazil
Prior art keywords
granules
orally administered
hexahydropyrazine derivatives
hexahydropyrazine
derivatives
Prior art date
Application number
BR9710377A
Other languages
English (en)
Other versions
BR9710377B1 (pt
Inventor
Jochen Kalbe
Terence Kopkins
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9710377A publication Critical patent/BR9710377A/pt
Publication of BR9710377B1 publication Critical patent/BR9710377B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
BRPI9710377-2A 1996-07-17 1997-07-04 gránulos de praziquantel administráveis por via oral a gatos. BR9710377B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19628776A DE19628776A1 (de) 1996-07-17 1996-07-17 Oral applizierbare Granulate von Hexahydropyrazinderivaten
PCT/EP1997/003537 WO1998003157A1 (de) 1996-07-17 1997-07-04 Oral applizierbare granulate von hexahydropyrazinderivaten

Publications (2)

Publication Number Publication Date
BR9710377A true BR9710377A (pt) 1999-08-17
BR9710377B1 BR9710377B1 (pt) 2011-10-18

Family

ID=7800044

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9710377-2A BR9710377B1 (pt) 1996-07-17 1997-07-04 gránulos de praziquantel administráveis por via oral a gatos.

Country Status (17)

Country Link
US (1) US6503536B2 (pt)
EP (1) EP0912167B1 (pt)
JP (1) JP4202422B2 (pt)
KR (1) KR100485149B1 (pt)
CN (1) CN1225579A (pt)
AT (1) ATE227565T1 (pt)
AU (1) AU711705B2 (pt)
BR (1) BR9710377B1 (pt)
CA (1) CA2260889C (pt)
DE (2) DE19628776A1 (pt)
DK (1) DK0912167T3 (pt)
ES (1) ES2183200T3 (pt)
HU (1) HUP9903180A3 (pt)
NO (1) NO325272B1 (pt)
NZ (1) NZ333745A (pt)
PT (1) PT912167E (pt)
WO (1) WO1998003157A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2767173T3 (es) * 2002-08-13 2020-06-16 Intervet Int Bv Composiciones y proceso para administrar un aditivo
US20040180034A1 (en) * 2003-03-10 2004-09-16 Lyn Hughes Anthelmintic resinates and a method for their preparation
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
MD20170009A2 (ro) 2012-02-06 2017-07-31 Merial Limited Compoziţii veterinare antiparazitare orale cu conţinut de agenţi activi cu acţiune sistemică, metode şi aplicări ale acestora
CN109010296A (zh) 2012-04-04 2018-12-18 英特维特国际股份有限公司 异噁唑啉化合物的固体口服药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
DE3472678D1 (de) 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3623321A1 (de) 1986-07-11 1988-01-21 Bayer Ag Verfahren zur kontinuierlichen herstellung von sphaerischen granulaten
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
CN1099973A (zh) * 1993-09-08 1995-03-15 四川省医学科学院寄生虫病防治研究所 兽用驱虫药物复方制剂
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations

Also Published As

Publication number Publication date
KR20000067862A (ko) 2000-11-25
AU3541397A (en) 1998-02-10
CA2260889C (en) 2007-09-11
ES2183200T3 (es) 2003-03-16
KR100485149B1 (ko) 2005-04-25
NO990157D0 (no) 1999-01-14
NZ333745A (en) 2000-10-27
JP2000515519A (ja) 2000-11-21
DK0912167T3 (da) 2003-03-10
CA2260889A1 (en) 1998-01-29
US6503536B2 (en) 2003-01-07
CN1225579A (zh) 1999-08-11
US20010055598A1 (en) 2001-12-27
EP0912167A1 (de) 1999-05-06
PT912167E (pt) 2003-03-31
NO325272B1 (no) 2008-03-17
DE59708723D1 (de) 2002-12-19
WO1998003157A1 (de) 1998-01-29
AU711705B2 (en) 1999-10-21
ATE227565T1 (de) 2002-11-15
EP0912167B1 (de) 2002-11-13
BR9710377B1 (pt) 2011-10-18
JP4202422B2 (ja) 2008-12-24
NO990157L (no) 1999-01-14
HUP9903180A2 (hu) 2000-04-28
DE19628776A1 (de) 1998-01-22
HUP9903180A3 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
EA200100838A1 (ru) Конъюгаты гксф
EA199901015A1 (ru) 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
DE69829175D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
EA199800357A1 (ru) Фармацевтические ангиостатические дипептидные композиции и способы их применения
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
NO910213L (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
IL105646A0 (en) Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them
BR9710377A (pt) Gr-nulos de derivados de hexahidropirazina administr veis por via oral
NO952743D0 (no) Ny benzotiadiazinforbindelse, dens fremstilling og farmasöytiske preparater
ATE90339T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
NO975127L (no) Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater
PH27567A (en) Topical compositions
BR0107630A (pt) Composição
IL67686A (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them
CA2383755A1 (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
KR910000645A (ko) 개선된 경련치료제
JPS5248677A (en) Preparation of pyrimidine derivatives
FI930300A (fi) 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste
ES2150400A6 (es) Una composicion para el tratamiento de desordenes ulcerosos del tracto gastrointestinal.
JPS5223068A (en) Preparation of optically active 1-methyl -2-(2'-(alpha-methyl-p-chlorobenz hydryloxy) ethtyl) pyrrolidine fumarates
RU96106995A (ru) Свечи с лидазой
IT8619384A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
JPS5294420A (en) Anti-coccidium agents for livestocks

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NOS ARTS. 8O, 13 E 24 DA LPI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/10/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)